 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 12 | 1/1 | 返回列表 |
| 查看: 263 | 回復(fù): 11 | |||
[交流]
【深容SCI寫作智能體】Abstract實測
|
|||
|
【深容SCI寫作智能體】Abstract實測 如需試用【深容SCI寫作智能體】，請聯(lián)系深容張老師：shenrongagent [https://scioriginal.com] 上月深容推出了【深容SCI寫作智能體】的Method，Introduction，Discussion智能體，寫作質(zhì)量非常高，全部真實參考文獻，深受用戶歡迎。 今天介紹的Abstract寫作智能體，功能相對簡單，根據(jù)用戶提供的正文內(nèi)容，快速起草摘要，同時輸出結(jié)構(gòu)式摘要和一體式摘要。 1. 用戶輸入正文內(nèi)容： 2. 檢索參考同類題材的摘要格式： 3. 輸出結(jié)果Abstract。 智能體的寫作質(zhì)量非常高： (1) Structured ABSTRACT 1) Background Signal Transducer and Activator of Transcription 2 (STAT2) is well-known for its role in type I interferon (IFN-I) signaling, which is generally considered tumor-suppressive. However, its direct role in cancer, particularly colorectal cancer (CRC), remains underexplored. Given the critical involvement of immune and cytokine networks in CRC progression, elucidating STAT2's contribution is essential. 2) Methods We analyzed TCGA-COAD datasets to assess STAT2 and IFNAR1 expression and patient survival. Human HCT116 and murine MC38 cell lines with STAT2 or IFNAR1 knockouts were generated using CRISPR\/Cas9 technology. Cell proliferation was measured in vitro using the CellTiter 96 assay. In vivo tumor growth was evaluated by subcutaneous injection of knockout and control cells into immunodeficient or immunocompetent mice. Western blot and qPCR analyses were performed to assess downstream signaling and gene expression changes. 3) Results High STAT2 expression in TCGA-COAD tumors correlated with reduced patient survival, independent of IFNAR1 levels. STAT2 deletion impaired cell proliferation and tumor growth in both human and murine models, whereas IFNAR1 deletion did not. STAT2 KO cells exhibited reduced STAT1 activation but enhanced STAT3 phosphorylation, indicating distinct downstream signaling effects compared to IFNAR1 KO cells. These findings suggest that STAT2 promotes tumorigenicity through mechanisms distinct from canonical IFN-I signaling. 4) Conclusion Our study reveals that STAT2 functions as a tumor-promoting factor in CRC, acting independently of IFNAR1-mediated IFN-I signaling. Targeting STAT2 or its downstream pathways may offer a novel therapeutic strategy for mitigating CRC progression. --- (2) Integrated ABSTRACT Signal Transducer and Activator of Transcription 2 (STAT2) is a key mediator of type I interferon (IFN-I) signaling, traditionally viewed as tumor-suppressive. However, its direct role in colorectal cancer (CRC) remains poorly defined, despite the critical influence of immune and cytokine networks on disease progression. To address this gap, we analyzed TCGA-COAD datasets and found that high STAT2 expression in CRC tumors correlated with reduced patient survival, independent of IFNAR1 levels. Using CRISPR\/Cas9 technology, we generated human HCT116 and murine MC38 cell lines with STAT2 or IFNAR1 knockouts. In vitro cell proliferation assays demonstrated that STAT2 deletion significantly impaired growth, whereas IFNAR1 deletion had no effect. In vivo studies in immunodeficient and immunocompetent mice confirmed that STAT2 KO cells formed smaller tumors compared to controls, while IFNAR1 KO cells did not differ significantly from wild-type cells. Western blot and qPCR analyses revealed that STAT2 deletion reduced STAT1 activation but enhanced STAT3 phosphorylation, indicating distinct downstream signaling effects compared to IFNAR1 KO cells. These findings suggest that STAT2 promotes tumorigenicity through mechanisms independent of canonical IFN-I signaling. Our study highlights STAT2 as a potential therapeutic target in CRC, offering new avenues for mitigating disease progression by targeting its pro-tumorigenic pathways. 以上這篇Abstract起草時間僅00:01:35 【深容SCI寫作智能體】包括四大模塊：Method智能體、Introduction智能體、Discussion智能體、Abstract智能體。 如需試用智能體，請徽售聯(lián)系深容張老師：shenrongagent [https://scioriginal.com] #SCI論文 #科研 #實驗 #博士 #投稿 |
回復(fù)此樓» 猜你喜歡
中國林科院林化所（南京）2026年招收化學(xué)/材料/環(huán)境工程等背景碩士研究生3名
已經(jīng)有3人回復(fù)
-
306求調(diào)劑
已經(jīng)有7人回復(fù)
-
0703化學(xué) 學(xué)碩 理工科均可 不區(qū)分研究方向 總分279求調(diào)劑
已經(jīng)有4人回復(fù)
-
0856材料工程，初試313調(diào)劑
已經(jīng)有7人回復(fù)
-
化工專碩調(diào)劑
已經(jīng)有7人回復(fù)
-
085600 英一數(shù)二272求調(diào)劑
已經(jīng)有44人回復(fù)
-
歡迎采礦、地質(zhì)、巖土、計算機、人工智能等專業(yè)的同學(xué)報考
已經(jīng)有10人回復(fù)
-
298求調(diào)劑一志愿中海洋
已經(jīng)有3人回復(fù)
-
環(huán)境調(diào)劑
已經(jīng)有7人回復(fù)
-
0703化學(xué)306調(diào)劑
已經(jīng)有4人回復(fù)
» 搶金幣啦！回帖就可以得到:
-
東南大學(xué)羅雄劍課題組招聘啟事
+2/176
-
中科院強磁場中心高薪誠聘博士后（有機化學(xué)）
+3/125
-
坐標廣州，征女友
+2/114
-
江西科技師范大學(xué)微生物天然藥物2026研究生調(diào)劑招生
+1/93
-
江西科技師范大學(xué)微生物天然藥物2026研究生調(diào)劑招生
+1/87
-
2026年青島理工大學(xué)暖通專業(yè)碩士生招生_081404方向&0852方向
+2/68
-
華中科技大學(xué)材料學(xué)院國家級人才團隊招收2026年碩士研究生
+1/35
-
2026年五邑大學(xué)化學(xué)工程與技術(shù)、材料與化工專業(yè)招收研究生
+1/34
-
哈工大鄭州研究院查正寶研究員招收博士生加盟
+1/34
-
中山大學(xué)化學(xué)工程與技術(shù)學(xué)院杰青歐陽鋼鋒/吳鑫課題組博士后招聘啟事
+1/29
-
華中科技大學(xué)牛廣達教授招聘博士后
+1/18
-
武漢-江漢大學(xué)-土木建筑工程類調(diào)劑招生
+3/12
-
長江大學(xué)農(nóng)學(xué)院 2026 碩士招生
+1/11
-
【碩士調(diào)劑招生】武漢科技大學(xué)招收材料、化工、環(huán)境、冶金類2026級碩士生
+1/11
-
西安電子科學(xué)大學(xué)杭州研究院劉麗香教授招收智能多模態(tài)傳感器和微型儲能器件方向博士
+1/7
-
重醫(yī)大-藥學(xué)院-藥學(xué)化學(xué)26級博士招生
+1/4
-
山西師范大學(xué) 材料科學(xué)與工程學(xué)院招收碩士調(diào)劑生
+1/2
-
濟南大學(xué)耿兵氟化學(xué)課題組現(xiàn)招收2026級化學(xué)工程學(xué)碩專碩共4名
+1/1
-
140300設(shè)計，一志愿985，354求調(diào)劑
+1/1
-
085600華工349求調(diào)劑
+1/1
簡單回復(fù)
夏末末872樓
2026-01-11 18:20
回復(fù)
pheiphei2025(金幣+1): 謝謝參與
1 發(fā)自小木蟲手機客戶端
2026-01-11 18:31
回復(fù)
jiaoxg4樓
2026-01-11 18:39
回復(fù)
pheiphei2025(金幣+1): 謝謝參與
tfang5樓
2026-01-11 18:42
回復(fù)
pheiphei2025(金幣+1): 謝謝參與
2026-01-11 18:51
回復(fù)
pheiphei2025(金幣+1): 謝謝參與
2026-01-11 19:04
回復(fù)
toppaper8樓
2026-01-11 20:07
回復(fù)
XG-WUST9樓
2026-01-11 21:35
回復(fù)
pheiphei2025(金幣+1): 謝謝參與
up 發(fā)自小木蟲IOS客戶端
psylhh10樓
2026-01-11 22:21
回復(fù)
pheiphei2025(金幣+1): 謝謝參與
庚辰辛丑11樓
2026-01-12 07:28
回復(fù)
pheiphei2025(金幣+1): 謝謝參與
afit88812樓
2026-01-12 11:17
回復(fù)
相關(guān)版塊跳轉(zhuǎn)
我要訂閱樓主 pheiphei2025 的主題更新
| 12 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 306求調(diào)劑 +7 | 張張張張oo 2026-03-03 | 7/350 |
|
|---|---|---|---|---|
|
[考研] 266材料化工求調(diào)劑 +3 | 哇塞王帥 2026-03-03 | 3/150 |
|
|
|
[考研] 成績276，專業(yè)代碼0856求調(diào)劑 +7 | 小陳朵 2026-03-03 | 7/350 |
|
|
|
[考研] 0805總分292，求調(diào)劑 +12 | 幻想之殤 2026-03-01 | 12/600 |
|
|
|
[考研] 一志愿天津大學(xué)085600 319分 材料與化工 金屬方向 求調(diào)劑 +4 | 青科11 2026-03-02 | 4/200 |
|
|
|
[考研] 環(huán)境工程學(xué)碩288求助調(diào)劑 +5 | 多吃億口芝士 2026-03-02 | 5/250 |
|
|
|
[考研] 化工335求調(diào)劑 +5 | 摸摸貓貓頭 2026-03-02 | 5/250 |
|
|
|
[考研] 0854復(fù)試調(diào)劑 276 +5 | wmm9 2026-03-01 | 7/350 |
|
|
|
[考研] 306分材料調(diào)劑 +5 | chuanzhu川燭 2026-03-01 | 6/300 |
|
|
|
[考博] 26超級電容器申博 +3 | dhdjdjend 2026-02-25 | 3/150 |
|
|
|
[考研] 材料085601調(diào)劑 +5 | 多多子. 2026-03-02 | 5/250 |
|
|
|
[考研] 303求調(diào)劑 +5 | 今夏不夏 2026-03-01 | 5/250 |
|
|
|
[考研] 265分求調(diào)劑不調(diào)專業(yè)和學(xué)校有行學(xué)上就 +6 | 禮堂丁真258 2026-02-28 | 9/450 |
|
|
|
[考研] 求調(diào)劑 +3 | 熬夜的貓頭鷹 2026-03-02 | 3/150 |
|
|
|
[考研] 295求調(diào)劑 +8 | 19171856320 2026-02-28 | 8/400 |
|
|
|
[考研] 275求調(diào)劑 +3 | L-xin? 2026-03-01 | 6/300 |
|
|
|
[考研] 調(diào)劑 +3 | 13853210211 2026-03-02 | 4/200 |
|
|
|
[考研] 材料學(xué)調(diào)劑 +10 | 提神豆沙包 2026-02-28 | 12/600 |
|
|
|
[考研] 328求調(diào)劑 +3 | aaadim 2026-03-01 | 5/250 |
|
|
|
[考研] 304求調(diào)劑 +6 | 曼殊2266 2026-02-28 | 7/350 |
|